![Richard Brudnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Brudnick
Directeur/Membre du Conseil chez
INFLARX N.V.
Fortune : 1 M $ au 30/06/2026
Profil
Mr. Richard H.
Brudnick is an Independent Director at Scholar Rock Holding Corp., a Chief Business Officer at Prime Medicine, Inc., an Independent Director at Volition America, Inc., an Independent Non-Executive Director at InflaRx NV and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Scholar Rock Holding Corp., Volition America, Inc. and InflaRx NV.
Mr. Brudnick was previously employed as an Independent Director by VolitionRX Ltd., a Chief Business Officer & Head-Strategy by Codiak BioSciences, Inc., an Executive Vice President-Business Development by Bioverativ, Inc., a Senior VP-Corporate Development & Strategy by Biogen, Inc., and a President & Chief Executive Officer by James Brudnick Co., Inc. He also served on the board at Tamarix Pharma Ltd. He received his undergraduate degree from Massachusetts Institute of Technology, an undergraduate degree from MIT Sloan School of Management, a graduate degree from MIT Sloan School of Management and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 21 896 ( 0,02% ) | 1 M $ | 30/06/2026 | |
INFLARX N.V. 0,03% | 18/03/2026 | 50 000 ( 0,03% ) | 112 000 $ | 30/06/2026 |
PRIME MEDICINE, INC. 0,01% | 20/05/2025 | 20 000 ( 0,01% ) | 73 800 $ | 30/06/2026 |
Postes actifs de Richard Brudnick
| Sociétés | Poste | Début |
|---|---|---|
| INFLARX N.V. | Directeur/Membre du Conseil | 14/02/2019 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Membre du Conseil | 06/04/2023 |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Directeur/Membre du Conseil | 25/03/2021 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/01/2018 |
Anciens postes connus de Richard Brudnick
| Sociétés | Poste | Fin |
|---|---|---|
| VOLITIONRX LIMITED | Directeur/Membre du Conseil | 23/06/2023 |
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/07/2022 |
| BIOVERATIV INC | Corporate Officer/Principal | 01/03/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2016 |
James Brudnick Co., Inc. | Directeur Général | 02/01/1998 |
Formation de Richard Brudnick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
James Brudnick Co., Inc. | |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Health Services |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
